These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34080783)

  • 21. Metabolic syndrome across Europe: different clusters of risk factors.
    Scuteri A; Laurent S; Cucca F; Cockcroft J; Cunha PG; Mañas LR; Mattace Raso FU; Muiesan ML; Ryliškytė L; Rietzschel E; Strait J; Vlachopoulos C; Völzke H; Lakatta EG; Nilsson PM;
    Eur J Prev Cardiol; 2015 Apr; 22(4):486-91. PubMed ID: 24647805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and impact of metabolic syndrome in patients with multivessel coronary artery disease and acute coronary syndrome.
    Zhou J; Liu C; Zhou P; Li J; Chen R; Wang Y; Zhao X; Zhao H; Song L; Yan H
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2693-2699. PubMed ID: 34344543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of metabolic syndrome in Algerian rheumatoid arthritis patients. Correlation with disease activity and functional status.
    Slimani S; Abbas A; Ben Ammar A; Rahal F; Khider I; Khelif K; Ladjouze-Rezig A
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S425-S427. PubMed ID: 28395950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis.
    Hallajzadeh J; Safiri S; Mansournia MA; Khoramdad M; Izadi N; Almasi-Hashiani A; Pakzad R; Ayubi E; Sullman MJ; Karamzad N
    PLoS One; 2017; 12(3):e0170361. PubMed ID: 28333949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study.
    Šalamon L; Morović-Vergles J; Marasović-Krstulović D; Kehler T; Šakić D; Badovinac O; Vlak T; Novak S; Štiglić-Rogoznica N; Hanih M; Bedeković D; Grazio S; Kadojić M; Milas-Ahić J; Prus V; Stamenković D; Šošo D; Anić B; Babić-Naglić Ð; Gamulin S
    Rheumatol Int; 2015 Dec; 35(12):2047-57. PubMed ID: 26059944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies.
    Zhang J; Fu L; Shi J; Chen X; Li Y; Ma B; Zhang Y
    PLoS One; 2013; 8(10):e78151. PubMed ID: 24205134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.
    Abourazzak FE; Mansouri S; Najdi A; Tahiri L; Nejjari C; Harzy T
    Clin Rheumatol; 2014 Nov; 33(11):1549-55. PubMed ID: 24647982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis.
    Sahebari M; Goshayeshi L; Mirfeizi Z; Rezaieyazdi Z; Hatef MR; Ghayour-Mobarhan M; Akhlaghi S; Sahebkar A; Ferns GA
    ScientificWorldJournal; 2011 Jun; 11():1195-205. PubMed ID: 21666989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association and predictive value analysis for metabolic syndrome on systolic and diastolic heart failure in high-risk patients.
    Tang ZH; Wang L; Zeng F; Zhang K
    BMC Cardiovasc Disord; 2014 Sep; 14():124. PubMed ID: 25249273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between prevalence of hypertension and components of metabolic syndrome: the data from Kailuan community.
    Lu K; Ding R; Wang L; Wu S; Chen J; Hu D
    Clin Exp Hypertens; 2015; 37(4):303-7. PubMed ID: 25272319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.
    Curtis JR; John A; Baser O
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1282-91. PubMed ID: 22504829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study.
    de Resende Guimarães MFB; Rodrigues CEM; Gomes KWP; Machado CJ; Brenol CV; Krampe SF; de Andrade NPB; Kakehasi AM
    Adv Rheumatol; 2019 Oct; 59(1):44. PubMed ID: 31619287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
    Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
    Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension.
    Bello-Rodriguez BM; Sanchez-Cruz G; Delgado-Bustillo F; Asiama G
    Ghana Med J; 2013 Dec; 47(4):189-96. PubMed ID: 24669025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
    da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
    Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis : Impact on lipid status, glycoregulation, and risk for coronary heart disease.
    Ostojic P; Bartolovic D
    Z Rheumatol; 2016 Sep; 75(7):716-22. PubMed ID: 26555552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.
    Toms TE; Panoulas VF; John H; Douglas KM; Kitas GD
    Arthritis Res Ther; 2009; 11(4):R110. PubMed ID: 19607680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome in rheumatoid arthritis: case control study.
    Rostom S; Mengat M; Lahlou R; Hari A; Bahiri R; Hajjaj-Hassouni N
    BMC Musculoskelet Disord; 2013 Apr; 14():147. PubMed ID: 23621997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferritin, metabolic syndrome and its components: A systematic review and meta-analysis.
    Suárez-Ortegón MF; Ensaldo-Carrasco E; Shi T; McLachlan S; Fernández-Real JM; Wild SH
    Atherosclerosis; 2018 Aug; 275():97-106. PubMed ID: 29886355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.